CSIMarket
 


Nevro Corp   (NVRO)
Other Ticker:  
 
 

NVRO's Revenue Growth by Quarter and Year

Nevro 's Revenue results by quarter and year




NVRO Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 113.84 102.76 109.73
III Quarter September 103.52 100.47 93.21 108.46
II Quarter June 108.81 104.21 102.33 56.39
I Quarter March 96.33 87.84 88.61 87.47
FY   308.66 406.36 386.91 362.05



NVRO Revenue third quarter 2023 Y/Y Growth Comment
Nevro Corp reported Revenue growth of 3.03% year on year in the third quarter 2023, to $ 103.52 millions, this is lower than Nevro Corp 's recent average Revenue rise of 47.84%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 117 other companies have achieved higher Revenue growth. While Nevro Corp ' s Revenue increase of 3.03% ranks overall at the positon no. 1820 in the third quarter 2023.




NVRO Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 10.78 % -6.35 % -4.06 %
III Quarter September 3.03 % 7.79 % -14.06 % 8.29 %
II Quarter June 4.41 % 1.84 % 81.47 % -39.73 %
I Quarter March 9.67 % -0.87 % 1.3 % 6.48 %
FY   - 5.03 % 6.87 % -7.23 %

Financial Statements
Nevro 's third quarter 2023 Revenue $ 103.52 millions NVRO's Income Statement
Nevro 's third quarter 2022 Revenue $ 100.47 millions Quarterly NVRO's Income Statement
New: More NVRO's historic Revenue Growth >>


NVRO Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 13.31 % 10.25 % 1.17 %
III Quarter September -4.87 % -3.59 % -8.91 % 92.34 %
II Quarter June 12.96 % 18.64 % 15.48 % -35.53 %
I Quarter March -15.38 % -14.52 % -19.25 % -23.52 %
FY (Year on Year)   - 5.03 % 6.87 % -7.23 %




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #362
Overall #1820

Revenue Y/Y Growth Statistics
High Average Low
385.2 % 47.84 % -39.74 %
(Jun 30 2016)   (Jun 30 2020)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #362
Overall #1820
Revenue Y/Y Growth Statistics
High Average Low
385.2 % 47.84 % -39.74 %
(Jun 30 2016)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Nevro 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
115.06 % 10.28 % -35.53 %
(Dec 31 2015)  


NVRO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Nevro Corp disclosed fall in Revenue sequentially by -4.87% to $ 103.52 millions, from $ 108.81 millions achived a quarter before.

But that's not important concern, as Nevro 's Revenue generally gravitate to slow in this quarter Catherine P. Martin, market researcher based in Houston wrote.

Within Medical Equipment & Supplies industry 41 other companies have achieved higher Revenue quarter on quarter growth. While Nevro 's Revenue growth quarter on quarter, overall rank is 1173.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #42
Healthcare Sector #136
Overall #1173
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #42
Healthcare Sector #136
Overall #1173
Revenue Q/Q Growth Statistics
High Average Low
115.06 % 10.28 % -35.53 %
(Dec 31 2015)  


NVRO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Nevro Corp disclosed fall in Revenue from the second quarter by -4.87% to $ 103.52 millions, from $ 108.81 millions released in the previous quarter.

But that's not big issue, as III. Quarter Revenue always gravitate to dip in the III. Quarter Catherine P. Martin, market researcher based in Houston told.

Within Medical Equipment & Supplies industry 41 other companies have achieved higher Revenue quarter on quarter growth. While Nevro 's Revenue growth quarter on quarter, overall rank is 1173.


Nevro 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 422.50 $ 419.45 $ 414.85 $ 406.37 $ 395.28
Y / Y Revenue Growth (TTM) 6.88 % 8.1 % 7.44 % 5.03 % 0.36 %
Year on Year Revenue Growth Overall Ranking # 906 # 580 # 305 # 1433 # 1361
Seqeuential Revenue Change (TTM) 0.73 % 1.11 % 2.09 % 2.8 % 1.87 %
Seq. Revenue Growth (TTM) Overall Ranking # 854 # 522 # 2196 # 2772 # 1039




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2023 period, Nevro 's cumulative twelve months Revenue were $ 423 millions, company would post below average annual Revenue growth of 1.87% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Nevro 's Revenue growth from the 108.81% growth in Jun 30 2023.

In the Healthcare sector 104 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 580 to 906.

Revenue TTM Q/Q Growth Statistics
High Average Low
228.28 %
26.37 %
-8.19 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 34
Healthcare Sector # 105
Overall # 906

Revenue TTM Y/Y Growth Statistics
High Average Low
228.28 %
26.37 %
-8.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 100
S&P 500 # 854
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2023 period, Nevro 's cumulative twelve months Revenue were $ 423 millions, company would post below average annual Revenue growth of -8.19% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Nevro 's Revenue growth from the 108.81% growth in Jun 30 2023.

In the Healthcare sector 104 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 580 to 906.

Revenue TTM Q/Q Growth Statistics
High Average Low
228.28 %
26.37 %
-8.19 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 34
Healthcare Sector # 105
Overall # 906

Revenue TTM Y/Y Growth Statistics
High Average Low
228.28 %
26.37 %
-8.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 100
S&P 500 # 854




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NVRO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NVRO's Competitors
Revenue Growth for Nevro 's Suppliers
Revenue Growth for NVRO's Customers

You may also want to know
NVRO's Annual Growth Rates NVRO's Profitability Ratios NVRO's Asset Turnover Ratio NVRO's Dividend Growth
NVRO's Roe NVRO's Valuation Ratios NVRO's Financial Strength Ratios NVRO's Dividend Payout Ratio
NVRO's Roa NVRO's Inventory Turnover Ratio NVRO's Growth Rates NVRO's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Inspiremd Inc 5.27%$ 5.271 millions
Amarin Corp Plcuk5.09%$ 5.086 millions
Seer Inc 5.08%$ 5.082 millions
Luna Innovations Inc5.06%$ 5.063 millions
Zimmer Biomet Holdings Inc 5.02%$ 5.019 millions
Iqvia Holdings Inc 4.88%$ 4.885 millions
Ironwood Pharmaceuticals inc 4.70%$ 4.696 millions
Aclarion Inc 4.63%$ 4.626 millions
Aridis Pharmaceuticals Inc 4.51%$ 4.511 millions
Avalon Globocare Corp 4.38%$ 4.379 millions
Assertio Holdings inc 4.14%$ 4.136 millions
Integrated Biopharma Inc4.11%$ 4.105 millions
Innoviva Inc 3.93%$ 3.928 millions
Ufp Technologies Inc 3.90%$ 3.898 millions
Elanco Animal Health Inc3.89%$ 3.891 millions
Charles River Laboratories International inc 3.79%$ 3.788 millions
Amgen Inc 3.77%$ 3.773 millions
Owens and Minor inc3.77%$ 3.768 millions
Sight Sciences Inc 3.51%$ 3.507 millions
Pediatrix Medical Group Inc 3.41%$ 3.408 millions
Halozyme Therapeutics Inc 3.38%$ 3.377 millions
Jazz Pharmaceuticals Plc3.35%$ 3.347 millions
Henry Schein Inc3.10%$ 3.097 millions
Nevro Corp 3.04%$ 3.036 millions
Cv Sciences Inc 2.45%$ 2.453 millions
Bio techne Corp2.45%$ 2.447 millions
Cardiff Lexington Corporation2.30%$ 2.302 millions
Nektar Therapeutics2.20%$ 2.197 millions
Community Health Systems Inc 2.02%$ 2.017 millions
Anika Therapeutics Inc 1.69%$ 1.689 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com